04.10.19
ChargePoint Technology, a provider of contained and sterile transfer solutions, has introduced new, single use additions to its portfolio: the ChargePoint Single Use Passive (SUP) and ChargeBag PE-S with new HiPure ULP7 PE film.
Together, the two products form a high performance, single use package for the contained and sterile transfer of pharmaceutical powders between manufacturing process steps and facilities.
The ChargePoint SUP is a disposable version of the passive mating half of the ChargePoint SBV (Split Butterfly Valve) technology, which forms a complete hybrid system and ensures the new single use products are compatible with existing ChargePoint SBV systems in the field.
Constructed completely of FDA and USP Class VI compliant materials, the SUP is both lightweight and cost effective, delivering containment and sterility assurance performance while eliminating the time and cost associated with cleaning, maintenance and Validation .
The new ChargeBag PE-S is a flexible, single use product container for the handling, storage and transfer of Biopharmaceutical powders. Manufactured from HiPure ULP7, a new proprietary film developed by ChargePoint, and Compliance tested to meet the demands of Aseptic Processing environments, the Solution is designed to enable high levels of integrity with optimized purity and robustness characteristics.
“As pharmaceutical manufacturing environments evolve, we will continue to push the boundaries of innovation and remain at the forefront of contained transfer advancements, responding to the challenges of today and tomorrow,” said Chris Eccles, chief executive officer, ChargePoint Technology. “We are excited to take our first steps into the realm of single use technology as we look for new ways to deliver compliant, flexible solutions to our customers.
“While traditional single use technologies claim to deliver the same level of performance as some of the more robust solutions, the reality is that this is not the case over repeated operations. ChargePoint’s hybrid solution delivers repeatable performance as well as offering several advantages to pharmaceutical manufacturers. The convenience and control benefits associated with pre-validated, ready to use solutions, that are easily integrated and perform to the highest level of containment and sterility assurance, are invaluable for our customers.”
In line with the next generation of transfer solutions, ChargePoint Technology is also introducing its latest update of the ChargePoint SBV system, Series 3. Featuring a new and improved locking mechanism with intuitive mechanical interlocks the system is operator friendly and reduces risk of part wear. On automatic versions, quick release actuators and sensor sockets ensure fast set up and changeover whilst improved access to the main disc seal makes maintenance steps more convenient than ever before.
Together, the two products form a high performance, single use package for the contained and sterile transfer of pharmaceutical powders between manufacturing process steps and facilities.
The ChargePoint SUP is a disposable version of the passive mating half of the ChargePoint SBV (Split Butterfly Valve) technology, which forms a complete hybrid system and ensures the new single use products are compatible with existing ChargePoint SBV systems in the field.
Constructed completely of FDA and USP Class VI compliant materials, the SUP is both lightweight and cost effective, delivering containment and sterility assurance performance while eliminating the time and cost associated with cleaning, maintenance and Validation .
The new ChargeBag PE-S is a flexible, single use product container for the handling, storage and transfer of Biopharmaceutical powders. Manufactured from HiPure ULP7, a new proprietary film developed by ChargePoint, and Compliance tested to meet the demands of Aseptic Processing environments, the Solution is designed to enable high levels of integrity with optimized purity and robustness characteristics.
“As pharmaceutical manufacturing environments evolve, we will continue to push the boundaries of innovation and remain at the forefront of contained transfer advancements, responding to the challenges of today and tomorrow,” said Chris Eccles, chief executive officer, ChargePoint Technology. “We are excited to take our first steps into the realm of single use technology as we look for new ways to deliver compliant, flexible solutions to our customers.
“While traditional single use technologies claim to deliver the same level of performance as some of the more robust solutions, the reality is that this is not the case over repeated operations. ChargePoint’s hybrid solution delivers repeatable performance as well as offering several advantages to pharmaceutical manufacturers. The convenience and control benefits associated with pre-validated, ready to use solutions, that are easily integrated and perform to the highest level of containment and sterility assurance, are invaluable for our customers.”
In line with the next generation of transfer solutions, ChargePoint Technology is also introducing its latest update of the ChargePoint SBV system, Series 3. Featuring a new and improved locking mechanism with intuitive mechanical interlocks the system is operator friendly and reduces risk of part wear. On automatic versions, quick release actuators and sensor sockets ensure fast set up and changeover whilst improved access to the main disc seal makes maintenance steps more convenient than ever before.
